Dr. Kelly E. Caudle discusses considerations behind CPIC guideline development and ongoing work to continually evolve the list of drug-gene interactions recognized by regulatory bodies. Learn about:
- Translating genetic laboratory test results into actionable prescribing decisions
- CPIC’s goal to address the barrier to clinical implementation of pharmacogenetic tests
- Ongoing efforts to provide practice guidelines that align to actionable pharmacogenomic information
PRESENTED BY:
Kelly E. Caudle, PharmD, PhD, BCPS
Principal Investigator and Director,
Clinical Pharmacogenetics Implementation Consortium
Learn more about our pharmacogenetics solutions.
